Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupus.

Leiss H, Salzberger W, Jacobs B, Gessl I, Kozakowski N, Blüml S, Puchner A, Kiss A, Podesser BK, Smolen JS, Stummvoll GH.

PLoS One. 2017 Jul 18;12(7):e0181015. doi: 10.1371/journal.pone.0181015. eCollection 2017.

2.

Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF+ T Lymphocytes.

Bystrom J, Clanchy FI, Taher TE, Al-Bogami MM, Muhammad HA, Alzabin S, Mangat P, Jawad AS, Williams RO, Mageed RA.

Clin Rev Allergy Immunol. 2017 Oct;53(2):265-276. doi: 10.1007/s12016-017-8610-y.

3.

Interluekin-17A (IL17A).

Chen K, Kolls JK.

Gene. 2017 May 30;614:8-14. doi: 10.1016/j.gene.2017.01.016. Epub 2017 Jan 22. Review.

PMID:
28122268
4.

Lupus pathobiology based on genomics.

Saeed M.

Immunogenetics. 2017 Jan;69(1):1-12. doi: 10.1007/s00251-016-0961-7. Epub 2016 Dec 8. Review.

5.

IL-17 mediates neutrophil infiltration and renal fibrosis following recovery from ischemia reperfusion: compensatory role of natural killer cells in athymic rats.

Mehrotra P, Collett JA, McKinney SD, Stevens J, Ivancic CM, Basile DP.

Am J Physiol Renal Physiol. 2017 Mar 1;312(3):F385-F397. doi: 10.1152/ajprenal.00462.2016. Epub 2016 Nov 16.

PMID:
27852609
6.

Phage display-derived human antibodies in clinical development and therapy.

Frenzel A, Schirrmann T, Hust M.

MAbs. 2016 Oct;8(7):1177-1194. Epub 2016 Jul 14. Review.

7.

Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.

Cai Z, Wong CK, Dong J, Chu M, Jiao D, Kam NW, Lam CW, Tam LS.

Clin Exp Immunol. 2015 Aug;181(2):253-66. doi: 10.1111/cei.12639.

8.

T cell and dendritic cell abnormalities synergize to expand pro-inflammatory T cell subsets leading to fatal autoimmunity in B6.NZBc1 lupus-prone mice.

Talaei N, Cheung YH, Landolt-Marticorena C, Noamani B, Li T, Wither JE.

PLoS One. 2013 Sep 20;8(9):e75166. doi: 10.1371/journal.pone.0075166. eCollection 2013.

9.

Clinical associations of serum interleukin-17 in systemic lupus erythematosus.

Vincent FB, Northcott M, Hoi A, Mackay F, Morand EF.

Arthritis Res Ther. 2013 Aug 23;15(4):R97. doi: 10.1186/ar4277.

10.

Suppressive oligodeoxynucleotides promote the development of Th17 cells.

Bode C, Yang XP, Kiu H, Klinman DM.

PLoS One. 2013 Jul 2;8(7):e67991. doi: 10.1371/journal.pone.0067991. Print 2013.

11.

Immune and inflammatory role in renal disease.

Imig JD, Ryan MJ.

Compr Physiol. 2013 Apr;3(2):957-76. doi: 10.1002/cphy.c120028. Review.

12.

Requirements for innate immune pathways in environmentally induced autoimmunity.

Pollard KM, Kono DH.

BMC Med. 2013 Apr 4;11:100. doi: 10.1186/1741-7015-11-100. Review.

13.

Cutting edge: Leptin-induced RORγt expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus.

Yu Y, Liu Y, Shi FD, Zou H, Matarese G, La Cava A.

J Immunol. 2013 Apr 1;190(7):3054-8. doi: 10.4049/jimmunol.1203275. Epub 2013 Feb 27.

14.

Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.

Jacob CO, Yu N, Guo S, Jacob N, Quinn WJ 3rd, Sindhava V, Cancro MP, Goilav B, Putterman C, Migone TS, Stohl W.

Arthritis Rheum. 2013 Apr;65(4):1043-54. doi: 10.1002/art.37846.

15.

Anti-tumor necrosis factor α treatment of interferon-α-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation.

Bethunaickan R, Sahu R, Liu Z, Tang YT, Huang W, Edegbe O, Tao H, Ramanujam M, Madaio MP, Davidson A.

Arthritis Rheum. 2012 Oct;64(10):3399-408. doi: 10.1002/art.34553.

16.

The discovery and development of belimumab: the anti-BLyS-lupus connection.

Stohl W, Hilbert DM.

Nat Biotechnol. 2012 Jan 9;30(1):69-77. doi: 10.1038/nbt.2076.

17.

Increased expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus erythematosus T lymphocytes promotes Th17 differentiation.

Chatterjee M, Rauen T, Kis-Toth K, Kyttaris VC, Hedrich CM, Terhorst C, Tsokos GC.

J Immunol. 2012 Feb 1;188(3):1206-12. doi: 10.4049/jimmunol.1102773. Epub 2011 Dec 19.

18.

The current concept of T (h) 17 cells and their expanding role in systemic lupus erythematosus.

Perry D, Peck AB, Carcamo WC, Morel L, Nguyen CQ.

Arthritis. 2011;2011:810649. doi: 10.1155/2011/810649. Epub 2011 Mar 22.

19.

Transcriptional analysis of infiltrating T cells in kidney ischemia-reperfusion injury reveals a pathophysiological role for CCR5.

Ko GJ, Linfert D, Jang HR, Higbee E, Watkins T, Cheadle C, Liu M, Racusen L, Grigoryev DN, Rabb H.

Am J Physiol Renal Physiol. 2012 Mar 15;302(6):F762-73. doi: 10.1152/ajprenal.00335.2011. Epub 2011 Dec 7.

20.

Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice.

Jacob CO, Guo S, Jacob N, Pawar RD, Putterman C, Quinn WJ 3rd, Cancro MP, Migone TS, Stohl W.

Arthritis Rheum. 2012 May;64(5):1610-9. doi: 10.1002/art.33458.

Supplemental Content

Support Center